Biomedical Nanotechnology - Neelina H. Malsch
.pdfBIOMEDICAL
NANOTECHNOLOGY
BIOMEDICAL
NANOTECHNOLOGY
Edited by
Neelina H. Malsch
Boca Raton London New York Singapore
CRC PRESS, a Taylor & Francis title, part of the Taylor and Francis Group.
Published in 2005 by CRC Press
Taylor & Francis Group
6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742
© 2005 by Taylor & Francis Group, LLC
CRC Press is an imprint of Taylor & Francis Group
No claim to original U.S. Government works
Printed in the United States of America on acid-free paper 10 9 8 7 6 5 4 3 2 1
International Standard Book Number-10: 0-8247-2579-4 (Hardcover)
International Standard Book Number-13: 978-0-8247-2579-2 (Hardcover)
Library of Congress Card Number 2005045702
This book contains information obtained from authentic and highly regarded sources. Reprinted material is quoted with permission, and sources are indicated. A wide variety of references are listed. Reasonable efforts have been made to publish reliable data and information, but the author and the publisher cannot assume responsibility for the validity of all materials or for the consequences of their use.
No part of this book may be reprinted, reproduced, transmitted, or utilized in any form by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying, microfilming, and recording, or in any information storage or retrieval system, without written permission from the publishers.
For permission to photocopy or use material electronically from this work, please access www.copyright.com (http://www.copyright.com/) or contact the Copyright Clearance Center, Inc. (CCC) 222 Rosewood Drive, Danvers, MA 01923, 978-750-8400. CCC is a not-for-profit organization that provides licenses and registration for a variety of users. For organizations that have been granted a photocopy license by the CCC, a separate system of payment has been arranged.
Trademark Notice: Product or corporate names may be trademarks or registered trademarks, and are used only for identification and explanation without intent to infringe.
Library of Congress Cataloging-in-Publication Data
Biomedical nanotechnology / edited by Neelina H. Malsch. p. cm.
Includes index. ISBN 0-8247-2579-4
1. Nanotechnology. 2. Medical technology. 3. Biomedical engineering. I. Malsch, Neelina H.
R857.N34B557 2005 |
|
610'.28--dc22 |
2005045702 |
Taylor & Francis Group
is the Academic Division of T&F Informa plc.
Visit the Taylor & Francis Web site at http://www.taylorandfrancis.com
and the CRC Press Web site at http://www.crcpress.com
Preface
In this book, we present the state of the art of nanotechnology research intended for applications in biomedical technologies in three subfields: nanodrugs and drug delivery inside the body; prostheses and implants; and diagnostics and screening technologies for laboratory use. For each of these three subfields, we explore the relevant developments in research.
Nanoparticles such as nanotubes and quantum dots are increasingly applied as drug delivery vehicles. Applications may include gene therapy, cancer treatments, and treatments for HIV and other diseases for which no cures presently exist. Implanted drug delivery or monitoring devices can also include nanostructured materials. Prostheses and implants include nanostructured materials. For example, hip replacements can be made to fit better into the body if coated with nanostructured materials. Nerve tissue can be made to grow along small silicon structures, and this may help paralyzed patients. Nanotechnologies may also contribute to electronic eyes and ears. The research on implants and prostheses focuses on two main directions: (1) biological nanostructures that put biological molecules and tissues in a strait jacket to grow into new structures and (2) biomimetic nanotechnology that starts with physical and chemical structures and aims for a completely new material.
Diagnostics and screening technologies include cantilever biochemical sensors, different types of scanning probe microscopes, lab-on-a-chip techniques, and biosensors. Nanoscience and nanotechnology focus on connecting living materials and electronics as well as on imaging and manipulating individual molecules.
We place these developments in social and economic contexts to assess the likelihood of uptake of these technologies and their relevance to the world’s most pressing health needs. Do real needs and markets exist for these devices? We also include a chapter exploring potential risks. The developments in the life science technologies involving GMOs, cloning, and stem cell research have shown that unexpected public concern may slow acceptance of new technologies. For nanotechnology, the public debate is just emerging. Researchers, government officials, and industrialists are actively attempting to assess the risks and redirect research toward the technologies consumers want and away from what the public will not accept.
The scope of this book includes scientific and technological details along with detailed discussions of social and economic contexts. The intended audience includes researchers active in nanoscience and technology in industry and academia, medical professionals, government officials responsible for research, innovation, health care, and biodefense, industrialists in pharmaceutical and biomedical technology, nongovernmental organizations interested in environmental, health care, or peace issues, students, and interested lay persons. We assume readers have academic training, but no expertise in nanotechnology.
Philip Antón
Rand Corporation
Santa Monica, California
Gabrielle Bloom
Rand Corporation
Santa Monica, California
Ian J. Bruce
Department of Biosciences
University of Kent
Canterbury, Kent, United Kingdom
Aránzazu del Campo
Department of Biosciences
Max-Planck Institut für
Metallforschung
Stuttgart, Germany
Brian Jackson
Rand Corporation
Santa Monica, California
John A. Jansen
University Medical Center Nijmegen
College of Dental Science
Nijmegen, The Netherlands
Ineke Malsch
Malsch TechnoValuation
Utrecht, The Netherlands
Mark Morrison
Institute of Nanotechnology
Stirling, Scotland
United Kingdom
Contributors
Mihail C. Roco
National Science Foundation
Chair, U.S. Nanoscale Science,
Engineering and Technology (NSET)
Washington, D.C.
Emmanuelle Schuler
Rice University
Houston, Texas
Calvin Shipbaugh
Rand Corporation
Santa Monica, California
Richard Silberglitt
Rand Corporation
Santa Monica, California
Jeroen J.J.P. van den Beucken
University Medical Center Nijmegen College of Dental Science Nijmegen, The Netherlands
X. Frank Walboomers
University Medical Center Nijmegen
College of Dental Science
Nijmegen, The Netherlands
Kenji Yamamoto, M.D., Ph.D.
Department of Medical Ecology and
Informatics
Research Institute of the International
Medical Center
Tokyo, Japan
Contents |
|
Introduction............................................................................................................... |
xi |
Converging Technologies: Nanotechnology and Biomedicine |
|
Mihail C. Roco |
|
Chapter 1 |
|
Trends in Biomedical Nanotechnology Programs Worldwide ................................. |
1 |
Mark Morrison and Ineke Malsch |
|
Chapter 2 |
|
Nanotechnology and Trends in Drug Delivery Systems with |
|
Self-Assembled Carriers.......................................................................................... |
29 |
Kenji Yamamoto |
|
Chapter 3 |
|
Implants and Prostheses .......................................................................................... |
41 |
Jeroen J.J.P. van den Beucken, X. Frank Walboomers, and |
|
John A. Jansen |
|
Chapter 4 |
|
Diagnostics and High Throughput Screening ......................................................... |
75 |
Aránzazu del Campo and Ian J. Bruce |
|
Chapter 5 |
|
Nano-Enabled Components and Systems for Biodefense .................................... |
113 |
Calvin Shipbaugh, Philip Antón, Gabrielle Bloom, Brian Jackson, and |
|
Richard Silberglitt |
|
Chapter 6 |
|
Social and Economic Contexts: Making Choices in the Development of |
|
Biomedical Nanotechnology ................................................................................. |
145 |
Ineke Malsch |
|
Chapter 7 |
|
Potential Risks and Remedies ............................................................................... |
177 |
Emmanuelle Schuler |
|
Index...................................................................................................................... |
201 |